Found: 36
Select item for more details and to access through your institution.
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2<sup>nd</sup>-line therapy for relapsed and refractory multiple myeloma - a phase II trial.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 770, doi. 10.1111/bjh.14481
- By:
- Publication type:
- Article
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2‐BCG): Final analysis of a multicenter, open‐label phase‐II‐trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1192, doi. 10.1002/ajh.27304
- By:
- Publication type:
- Article
Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 12, p. 2437, doi. 10.1007/s00277-018-3449-8
- By:
- Publication type:
- Article
Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 5, p. 653, doi. 10.1007/s00277-012-1660-6
- By:
- Publication type:
- Article
Synthese des Makrolid-Antibiotikums (−)-A26771B mit Photolactonisierung als Schlüsselreaktion und Computersimulation als effektive Optimierungshilfe.
- Published in:
- Helvetica Chimica Acta, 1991, v. 74, n. 8, p. 1853, doi. 10.1002/hlca.19910740828
- By:
- Publication type:
- Article
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 7/8, p. 340, doi. 10.1159/000536652
- By:
- Publication type:
- Article
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 11, p. 628, doi. 10.1159/000510258
- By:
- Publication type:
- Article
Bortezomib-Containing Regimens Are Effective in Multiple Myeloma - Results of a Non-Interventional Phase IV Study.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 4, p. 167, doi. 10.1159/000381297
- By:
- Publication type:
- Article
Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN).
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 11, p. 635, doi. 10.1159/000368315
- By:
- Publication type:
- Article
Aktuelle und künftige Indikationen mit Bendamustin: chronische lymphatische Leukämie, indolente Lymphome, Mantelzell-Lymphome und diffuse großzellige B-Zell-Lymphome.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, p. 11, doi. 10.1159/000346106
- By:
- Publication type:
- Article
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 2, p. 133, doi. 10.1111/ejh.13719
- By:
- Publication type:
- Article
Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 308, doi. 10.1111/ejh.13439
- By:
- Publication type:
- Article
First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 116, doi. 10.1111/ejh.13409
- By:
- Publication type:
- Article
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 139, doi. 10.1007/s10637-007-9106-z
- By:
- Publication type:
- Article
Similar effectiveness of R‐CHOP‐14 and ‐21 in diffuse large B‐cell lymphoma—data from the prospective German Tumour Registry Lymphatic Neoplasms.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 5, p. 460, doi. 10.1111/ejh.13295
- By:
- Publication type:
- Article
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e777, doi. 10.1016/j.clml.2022.04.007
- By:
- Publication type:
- Article
CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Initial experience with dynamic MR imaging in evaluation of normal bone marrow versus malignant bone marrow infiltrations in humans.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 313, doi. 10.1002/hon.2868
- By:
- Publication type:
- Article
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.
- Published in:
- Hematological Oncology, 2015, v. 33, n. 1, p. 15, doi. 10.1002/hon.2139
- By:
- Publication type:
- Article
Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Effect of Neurotensin on Exocrine Pancreatic Secretion in Dogs.
- Published in:
- Digestion, 1982, v. 23, n. 3, p. 174, doi. 10.1159/000198725
- By:
- Publication type:
- Article
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 1, p. 67, doi. 10.1111/bjh.12000
- By:
- Publication type:
- Article
Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft- versus-host disease.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 4, p. 568, doi. 10.1111/j.1365-2141.2005.05631.x
- By:
- Publication type:
- Article
Intramedullary abscess in a patient with disseminated Scedosporium apiospermum infection.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 5, p. 724, doi. 10.1046/j.1365-2141.2003.04117.x
- By:
- Publication type:
- Article
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 2, p. 342, doi. 10.1046/j.1365-2141.2001.02959.x
- By:
- Publication type:
- Article
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011.
- Published in:
- Oncology Letters, 2016, v. 12, n. 6, p. 5043, doi. 10.3892/ol.2016.5375
- By:
- Publication type:
- Article
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 12, p. 6431, doi. 10.3390/ijms25126431
- By:
- Publication type:
- Article
Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 45, doi. 10.1002/jha2.593
- By:
- Publication type:
- Article
CD82 (KAI1), a member of the tetraspan family, is expressed on early haemopoietic progenitor cells and up-regulated in distinct human leukaemias.
- Published in:
- British Journal of Haematology, 1999, v. 107, n. 3, p. 494, doi. 10.1046/j.1365-2141.1999.01741.x
- By:
- Publication type:
- Article
Interferon-alpha 2b (IFNα) for Early-Phase Chronic Lymphocytic Leukaemia with High Risk for Disease Progression: Results of a Randomized Multicentre Study.
- Published in:
- British Journal of Haematology, 1996, v. 94, n. 2, p. 362, doi. 10.1046/j.1365-2141.1996.d01-1796.x
- By:
- Publication type:
- Article